Methyl 5-(24-Difluorophenyl)-A-Methoxy-H-Pyrrole-3-Carboxylate

What Catalytic Step in Oncology API Production Requires Sub-2% Epimerization Tolerance?

Manufacture of the ATP-competitive kinase inhibitor clinical candidate containing a 2,4-difluorophenyl pyrrole carboxamide pharmacophore initiates with methyl 5-(2,4-difluorophenyl)-α-methoxy-1H-pyrrole-3-carboxylate as the regulatory starting material entered into the Drug Master File. In the pivotal amidation stage, the ester undergoes direct aminolysis with (S)-3-aminopiperidine dihydrochloride utilizing 1,1′-carbonyldiimidazole (CDI) in anhydrous tetrahydrofuran under a nitrogen blanket; the molar ratio of ester to amine is held at 1:1.08 to 1:1.15 to suppress racemization below 2.5% as verified by chiral HPLC (Chiralpak IA column, 254 nm). The reaction mass is maintained at 0 °C ± 3 °C for the first 4 hours and then allowed to warm to 20 °C over 2 hours, with conversion monitored via in situ ReactIR trend analysis tracking the carbonyl stretch shift from 1725 cm⁻¹ to 1690 cm⁻¹. Compliance with ICH Q7 Good Manufacturing Practice for active pharmaceutical ingredients is enforced through validated cleaning procedures for the glass-lined reactor (3000 L) and a dedicated wiped-film evaporator used to strip THF below 45 °C at 50 mbar. Downstream processing involves a charcoal filtration step, pH adjustment to 6.8–7.0 with 1 M HCl, and crystallization from isopropanol/water (70:30 v/v) yielding a white crystalline solid with chemical purity ≥99.5% by HPLC at 210 nm. The terminal product is the free base API packaged in double polyethylene bags within a fiber drum under argon, designated for Phase IIb clinical trial supply of an orally administered tablet formulation dosed at 50 mg and 150 mg strengths.

SDHI Fungicide Intermediate and Acyl Chloride Reactivity in Batch Processing

Conversion of the pyrrole ester into the corresponding acyl chloride is the rate-determining transformation in preparing a second-generation succinate dehydrogenase inhibitor (SDHI) active against Septoria tritici and Pyrenophora teres. Following saponification with 1.2 equivalents of aqueous sodium hydroxide (10% w/w) in methanol at 50 °C for 3 hours, the liberated carboxylic acid is isolated by acidification and dried to moisture content <0.1% before chlorination. The acid is suspended in toluene with a catalytic amount of N,N-dimethylformamide (0.05 eq) and treated with thionyl chloride (1.4 eq) at a controlled internal temperature of 38±2 °C inside a Hastelloy C-276 reactor; exceeding 42 °C triggers an exothermic decomposition pathway that generates a difluorobenzyne byproduct detectable by GC-MS at m/z 170. The resulting acid chloride solution is used directly without isolation to amidate 3-(trifluoromethyl)-1-methyl-1H-pyrazol-4-amine in the presence of triethylamine (1.2 eq) at 5–10 °C, delivering the SDHI intermediate in 82–88% yield after aqueous workup and trituration with n-heptane. Compliance is verified against FAO Specification E3F for technical grade active ingredients and CIPAC MT 18.2 for suspension concentrates. The industrial process utilizes a continuous-flow microchannel setup for the acylation stage to improve thermal control and reduce batch cycle time to 12 minutes residence time. Final formulation: the technical material is air-milled with lignosulfonate dispersant and blended into a 200 g/L SC formulation, applied at 1.0 L/ha in cereal fungicide programs.

In veterinary parasitology, methyl 5-(2,4-difluorophenyl)-α-methoxy-1H-pyrrole-3-carboxylate is employed as a key building block in the convergent synthesis of a cyclooctadepsipeptide anthelmintic active against macrocyclic lactone-resistant isolates of Haemonchus contortus in sheep. The ester is converted to the activated N-hydroxysuccinimidyl ester and coupled on-resin following Fmoc-solid-phase peptide synthesis protocols: the coupling stoichiometry uses 2.5 equivalents of the pyrrole-derived acid component relative to the resin-bound tetrapeptide intermediate, with HATU (2.4 eq) and N,N-diisopropylethylamine (5 eq) in N-methyl-2-pyrrolidone. Cleavage from the 2-chlorotrityl chloride resin with 1% trifluoroacetic acid in dichloromethane yields the fully protected linear precursor, which undergoes macrolactamization mediated by FDPP (3 eq) under high-dilution conditions (substrate concentration 0.002 M) in acetonitrile. Quality management follows VICH GL18 guidelines for active pharmaceutical ingredients intended for veterinary use, with residual solvent limits aligned with Ph. Eur. 5.4. The terminal dosage form is a 10% w/w oral paste administered via a calibrated dosing syringe, targeting a dose rate of 2.5 mg active per kg bodyweight.

When Light Stabilization in Polyolefin Compounding Demands Non-Phenolic Radical Scavengers

In polypropylene multifilament yarns destined for geotextile applications requiring 10-year UV exposure durability, the pyrrole ester is first functionalized via a Mannich-type reaction with paraformaldehyde and 2,2,6,6-tetramethylpiperidin-4-amine to yield a corresponding benzotriazole-analogue UV absorber with an extended π-conjugation across the pyrrole ring. Compounding on a co-rotating twin-screw extruder (L/D 40:1, screw diameter 35 mm) at a melt temperature of 230±5 °C incorporates the pre-dried additive at 0.22–0.35 wt% alongside calcium stearate (0.1 wt%) and a phosphite co-stabilizer (Irgafos 168, 0.08 wt%). Retention of the pyrrole moiety in the finished filament is confirmed by nitrogen-specific chemiluminescence detection, quantifying a bioavailability of active stabilizer ≥92% after processing. Accelerated weathering per ISO 4892-2:2013 (filtered xenon-arc, 0.50 W/m² at 340 nm, black panel temperature 65 °C) demonstrates that tensile strength retention exceeds 85% after 5000 hours, satisfying the durability requirement for landfill liner construction. The compounded granules meet indirect food-contact regulations under FDA 21 CFR 177.1520 (c) 3.1b and European Regulation (EU) No 10/2011 Annex II. Finished product: UV-stabilized PP yarn of 1200 denier woven into geotextile fabric for basal reinforcement of lined waste containment systems.

For lateral flow immunoassay development, the N-hydroxysuccinimidyl ester derivative prepared in situ from the pyrrole carboxylic acid is conjugated to a monoclonal anti-human CRP capture antibody at a molar excess of 10:1 (label-to-protein) in 0.1 M sodium bicarbonate buffer, pH 9.0, for 60 minutes at ambient temperature, followed by purification on a Sephadex G-25 column. The conjugate is dispensed onto a glass fiber conjugate pad and assembled into a test strip complying with ISO 13485:2016 design controls; the terminal device is a fluorescence-based point-of-care cassette that quantifies C-reactive protein from 5 μL of fingerstick whole blood within 8 minutes.

A sublimable precursor for vacuum-processed organic light-emitting diodes, the pyrrole ester—after chromatographic purification to 99.99% purity by train sublimation at 185 °C and 2×10⁻⁶ Torr—is co-deposited with the host material 4,4′-bis(N-carbazolyl)-1,1′-biphenyl (CBP) at a weight ratio of 6% dopant onto an indium tin oxide anode pre-coated with a hole-injection layer. The deposition rate is maintained at 0.3 Å/s using a quartz crystal microbalance under UHV conditions, yielding an electron-transporting emitting layer of 40 nm thickness. Stack performance is validated against IEC 62341-1-1:2014 for OLED display modules; the final application is a top-emission structure for automotive AMOLED dashboard displays requiring 120 cd/m² luminance at 4.5 V drive voltage.